Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of this study is to evaluate whether New Touch Digital (NTD) NeuroRPM software installed on wearable devices can objectively measure and track symptoms in patients with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedJanuary 11, 2023
December 1, 2022
1.4 years
June 21, 2022
December 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NeuroRPM UPDRS predicted score vs. clinical raters' UPDRS
We will compare symptom severity as predicted by NeuroRPM to UPDRS scores from clinical raters. Statistical significance will be evaluated by intraclass correlation and kappa-statistic.
Comparison will be performed upon completion of the study, approximately in 1 year.
Study Arms (1)
Parkinson's patients
Cohort of patients with clinical diagnosis of Parkinson's diseases with varied symptoms and severity.
Interventions
Eligibility Criteria
The study is open to persons 18 years of age and older with a clinical diagnosis of Parkinson's diseases without other neurological diseases.
You may qualify if:
- Subject is 18 years of age or older
- Subject is able to provide informed written consent
- Subject has been clinically diagnosed with Parkinson's Disease
- Subject is mentally and physically capable of performing tasks on the mobile device and related physical activities herein described
You may not qualify if:
- Inability to give informed consent
- Presence of additional neurological disease aside from the diseases being studied
- Inability to understand and follow the directions for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parkinson's & Movement Disorders Center of Maryland
Elkridge, Maryland, 21075, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2022
First Posted
January 11, 2023
Study Start
January 19, 2019
Primary Completion
June 1, 2020
Study Completion
August 1, 2023
Last Updated
January 11, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share